Alliancebernstein L.P. raised its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 5.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 1,439,164 shares of the real estate investment trust's stock after acquiring an additional 78,090 shares during the period. Alliancebernstein L.P. owned approximately 0.60% of Sabra Healthcare REIT worth $25,142,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. State of Michigan Retirement System lifted its stake in shares of Sabra Healthcare REIT by 1.1% in the first quarter. State of Michigan Retirement System now owns 56,649 shares of the real estate investment trust's stock valued at $990,000 after purchasing an additional 600 shares during the period. Louisiana State Employees Retirement System lifted its stake in shares of Sabra Healthcare REIT by 0.9% in the first quarter. Louisiana State Employees Retirement System now owns 66,300 shares of the real estate investment trust's stock valued at $1,158,000 after purchasing an additional 600 shares during the period. Harbor Capital Advisors Inc. lifted its stake in shares of Sabra Healthcare REIT by 17.2% in the first quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust's stock valued at $76,000 after purchasing an additional 642 shares during the period. Diversify Advisory Services LLC lifted its stake in shares of Sabra Healthcare REIT by 5.7% in the first quarter. Diversify Advisory Services LLC now owns 12,878 shares of the real estate investment trust's stock valued at $226,000 after purchasing an additional 689 shares during the period. Finally, IFP Advisors Inc lifted its stake in shares of Sabra Healthcare REIT by 16.2% in the first quarter. IFP Advisors Inc now owns 5,060 shares of the real estate investment trust's stock valued at $88,000 after purchasing an additional 706 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.
Sabra Healthcare REIT Trading Up 0.7%
SBRA stock traded up $0.14 during midday trading on Monday, reaching $19.19. 1,566,610 shares of the company's stock traded hands, compared to its average volume of 2,121,595. The company has a market capitalization of $4.60 billion, a P/E ratio of 25.25, a PEG ratio of 1.52 and a beta of 0.88. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The business has a 50-day moving average price of $18.70 and a two-hundred day moving average price of $18.01.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The firm had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same period in the previous year, the company posted $0.36 earnings per share. Sabra Healthcare REIT's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Healthcare REIT Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 6.3%. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.
Analyst Ratings Changes
SBRA has been the subject of a number of research reports. BMO Capital Markets lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research report on Monday, August 25th. Truist Financial lifted their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a research report on Tuesday, September 2nd. Wells Fargo & Company lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 27th. Scotiabank lifted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. Finally, JMP Securities lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $20.83.
Get Our Latest Research Report on Sabra Healthcare REIT
Sabra Healthcare REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also

Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.